Prednisone and Cyclosporine in the Treatment of Severe Graves' Ophthalmopathy

New England Journal of Medicine

Volumn 321, Issue 20, 1989, Pages 1353-1359

  Prummel, Mark F ^a   Mourits, Maarten Ph ^a   Berghout, Arie ^a   Krenning, Eric P ^a   Van Der Gaag, Ruth ^a   Koornneef, Leo ^a   Wiersinga, Wilmar M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; PREDNISONE;

CLINICAL ARTICLE; EYE DISEASE; GRAVES DISEASE; HUMAN; HYPERTENSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0024468387     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198911163212002     Document Type: Article

References (26)

1. Jacobson DH, Gorman CA. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment. Endocr Rev 1984; 5: 200–20.
2. Bahn RS, Gorman CA. Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy. Endocrinol Metab Clin North Am 1987; 16: 391–407.
3. Morris PJ. Cyclosporin A. Transplantation 1981; 32: 349–54.
4. Vladutiu AO. Effect of cyclosporine on experimental autoimmune thyroiditis in mice. Transplantation 1983; 35: 518–20.
5. Weetman AP, McGregor AM, Ludgate M, et al. Cyclosporine improves Graves' ophthalmopathy. Lancet 1983; 2: 486–9.
6. Utech C, Wulle KG, Kiefer H, Panitz N. Ciclosporin treatment in severe Graves' ophthalmopathy. In: Schindler R, ed. Ciclosporin in autoimmune diseases: first international symposium, Basel, Switzerland, March 18–20, 1985. Berlin: Springer-Verlag, 1985:247–52.
7. Kahaly G, Schrezenmeir J, Krause U, et al. Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study. Eur J Clin Invest 1986; 16: 415–22.
8. Landgraf R, Witte A, Markl A, Boergen KP, Hasenfratz G, Pickardt CR. Treatment of Graves' ophthalmopathy with ciclosporin. In: Schindler R, ed. Ciclosporin in autoimmune diseases: first international symposium, Basel, Switzerland, March 18–20, 1985. Berlin: Springer-Verlag, 1985:235–41.
9. Brabant G, Peter H, Becker H, Schwarzrock R, Wonigeit K, Hesch RD. Cyclosporine in infiltrative eye disease. Lancet 1984; 1: 515–6.
10. Howlett TA, Lawton NF, Fells P, Besser GM. Deterioration of severe Graves' ophthalmopathy during cyclosporin treatment. Lancet 1984; 2: 1101.
11. Witte A, Landgraf R, Markl A, Boergen KP, Hasenfratz G, Pickardt CR. Treatment of Graves' ophthalmopathy with cyclosporin A. Klin Wochenschr 1985; 63: 1000–4.
12. Karlsson FA, Dahlberg PA, Jansson R, Enoksson P, Thorgeirsson E, Tottermann T. A pilot study of ciclosporin in endocrine ophthalmopathy. In: Schindler R, ed. Ciclosporin in autoimmune diseases: first international symposium, Basel, Switzerland, March 18–20, 1985. Berlin: Springer-Verlag, 1985:242–6.
13. McGregor AM, Beck M, Weetman AP, Hall R. Ciclosporin in the management of Graves' ophthalmopathy. In: Schindler R, ed. Ciclosporin in autoimmune diseases: first international symposium, Basel, Switzerland, March 18–20, 1985. Berlin: Springer-Verlag, 1985:229–34.
14. Prummel MF, Wiersinga WM, Mourits M.Ph, Koornneef L, Berghout A, van der Gaag R. Amelioration of eye changes of Graves' ophthalmopathy by achieving euthyroidism. Acta Endocrinol Suppl (Copenh) (in press).
15. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 1977; 44: 203–4.
16. Duke-Elder S, Smith RJH. The examination of the visual functions. In: Duke-Elder S, ed. The foundations of ophthalmology: heredity, pathology, diagnosis, and therapeutics. Vol. 7 of System of ophthalmology. St. Louis: C.V. Mosby, 1962:370–3.
17. Wiersinga WM, Chopra IJ. Radioimmunoassay of thyroxine (T4), 3,5,3′-triiodothyronine (T3), 3,3′,5′-triiodothyronine (reverse T3, rT3), and 3,3′-diiodothyronine (T2). Methods Enzymol 1982; 84: 272–303.
18. Donaldson SS, Bagshaw MA, Kriss JP. Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 1973; 37: 276–85.
19. Cyclosporin in autoimmune disease. Lancet 1985; 1: 909–11.
20. Wiersinga WM, Smit T, Schuster-Uittenhoeve AL, van der Gaag R, Koornneef L. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy. Ophthalmologica 1988; 197: 75–84.
21. Gayno JP, Strauch G. Ciclosporine and Graves' ophthalmopathy. Horm Res 1987; 26: 190–7.
22. Bartalena L, Marcocci C, Chiovato L, et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 1983; 56: 1139–44.
23. Cortisone in exophthalmos: report on a therapeutic trial of cortisone and corticotrophin (A.C.T.H.) in exophthalmos and exophthalmoplegia by a panel appointed by the Medical Research Council. Lancet 1955; 1: 6–9.
24. Hurbli T, Char DH, Harris J, Weaver K, Greenspan F, Sheline G. Radiation therapy for thyroid eye diseases. Am J Ophthalmol 1985; 99: 633–7.
25. Teng CS, Crombie AL, Hall R, Ross WM. An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1980; 13: 545–51.
26. Mounts MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol 1989; 73: 639–44.